Granulocyte-colony stimulating factor promotes invasion by human lung cancer cell lines in vitro. 1996

X H Pei, and Y Nakanishi, and K Takayama, and J Yatsunami, and F Bai, and M Kawasaki, and K Wakamatsu, and N Tsuruta, and K Mizuno, and N Hara
Research Institute for Diseases of the Chest, Faculty of Medicine, Kyushu University, Fukuoka, Japan.

The effects of exogenous and endogenous granulocyte colony-stimulating factor (G-CSF) on invasion by cancer cells were studied, using lung cancer cell lines that produce G-CSF (NCI-H157) and lines that do not (PC-9 and NCI-H23). The invasive capacity of NCI-H157 cells was 26- to 27-fold higher than that of PC-9 and NCI-H23 cells. The invasiveness of PC-9 cells was stimulated by exogenous G-CSF, while that of NCI-H157 cells was not. Antibodies against G-CSF blocked the stimulation of PC-9 cell invasiveness by exogenous G-CSF. Anti G-CSF antibodies also inhibited invasion by NCI-H157 cells in the absence of exogenous G-CSF. These results suggest that endogenous and exogenous G-CSF both stimulate invasion by lung cancer cells.

UI MeSH Term Description Entries
D008175 Lung Neoplasms Tumors or cancer of the LUNG. Cancer of Lung,Lung Cancer,Pulmonary Cancer,Pulmonary Neoplasms,Cancer of the Lung,Neoplasms, Lung,Neoplasms, Pulmonary,Cancer, Lung,Cancer, Pulmonary,Cancers, Lung,Cancers, Pulmonary,Lung Cancers,Lung Neoplasm,Neoplasm, Lung,Neoplasm, Pulmonary,Pulmonary Cancers,Pulmonary Neoplasm
D009361 Neoplasm Invasiveness Ability of neoplasms to infiltrate and actively destroy surrounding tissue. Invasiveness, Neoplasm,Neoplasm Invasion,Invasion, Neoplasm
D002455 Cell Division The fission of a CELL. It includes CYTOKINESIS, when the CYTOPLASM of a cell is divided, and CELL NUCLEUS DIVISION. M Phase,Cell Division Phase,Cell Divisions,Division Phase, Cell,Division, Cell,Divisions, Cell,M Phases,Phase, Cell Division,Phase, M,Phases, M
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000906 Antibodies Immunoglobulin molecules having a specific amino acid sequence by virtue of which they interact only with the ANTIGEN (or a very similar shape) that induced their synthesis in cells of the lymphoid series (especially PLASMA CELLS).
D014407 Tumor Cells, Cultured Cells grown in vitro from neoplastic tissue. If they can be established as a TUMOR CELL LINE, they can be propagated in cell culture indefinitely. Cultured Tumor Cells,Neoplastic Cells, Cultured,Cultured Neoplastic Cells,Cell, Cultured Neoplastic,Cell, Cultured Tumor,Cells, Cultured Neoplastic,Cells, Cultured Tumor,Cultured Neoplastic Cell,Cultured Tumor Cell,Neoplastic Cell, Cultured,Tumor Cell, Cultured
D016179 Granulocyte Colony-Stimulating Factor A glycoprotein of MW 25 kDa containing internal disulfide bonds. It induces the survival, proliferation, and differentiation of neutrophilic granulocyte precursor cells and functionally activates mature blood neutrophils. Among the family of colony-stimulating factors, G-CSF is the most potent inducer of terminal differentiation to granulocytes and macrophages of leukemic myeloid cell lines. Colony-Stimulating Factor, Granulocyte,G-CSF,Myeloid Growth Factor,Colony Stimulating Factor, Granulocyte,Factor, Granulocyte Colony-Stimulating,Factor, Myeloid Growth,Granulocyte Colony Stimulating Factor,Growth Factor, Myeloid

Related Publications

X H Pei, and Y Nakanishi, and K Takayama, and J Yatsunami, and F Bai, and M Kawasaki, and K Wakamatsu, and N Tsuruta, and K Mizuno, and N Hara
April 1987, Journal of leukocyte biology,
X H Pei, and Y Nakanishi, and K Takayama, and J Yatsunami, and F Bai, and M Kawasaki, and K Wakamatsu, and N Tsuruta, and K Mizuno, and N Hara
December 1999, Human reproduction (Oxford, England),
X H Pei, and Y Nakanishi, and K Takayama, and J Yatsunami, and F Bai, and M Kawasaki, and K Wakamatsu, and N Tsuruta, and K Mizuno, and N Hara
January 1992, Brain research,
X H Pei, and Y Nakanishi, and K Takayama, and J Yatsunami, and F Bai, and M Kawasaki, and K Wakamatsu, and N Tsuruta, and K Mizuno, and N Hara
May 2001, Clinical chemistry and laboratory medicine,
X H Pei, and Y Nakanishi, and K Takayama, and J Yatsunami, and F Bai, and M Kawasaki, and K Wakamatsu, and N Tsuruta, and K Mizuno, and N Hara
October 2007, Hematology (Amsterdam, Netherlands),
X H Pei, and Y Nakanishi, and K Takayama, and J Yatsunami, and F Bai, and M Kawasaki, and K Wakamatsu, and N Tsuruta, and K Mizuno, and N Hara
March 1996, Gynecologic oncology,
X H Pei, and Y Nakanishi, and K Takayama, and J Yatsunami, and F Bai, and M Kawasaki, and K Wakamatsu, and N Tsuruta, and K Mizuno, and N Hara
October 2015, Oncogene,
X H Pei, and Y Nakanishi, and K Takayama, and J Yatsunami, and F Bai, and M Kawasaki, and K Wakamatsu, and N Tsuruta, and K Mizuno, and N Hara
April 2012, Cancer biology & therapy,
X H Pei, and Y Nakanishi, and K Takayama, and J Yatsunami, and F Bai, and M Kawasaki, and K Wakamatsu, and N Tsuruta, and K Mizuno, and N Hara
October 1994, International journal of cancer,
X H Pei, and Y Nakanishi, and K Takayama, and J Yatsunami, and F Bai, and M Kawasaki, and K Wakamatsu, and N Tsuruta, and K Mizuno, and N Hara
February 1994, Seminars in oncology,
Copied contents to your clipboard!